Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFondul Proprietatea Regulatory News (FP.)

Share Price Information for Fondul Proprietatea (FP.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.78
Bid: 4.60
Ask: 4.72
Change: -0.02 (-0.42%)
Spread: 0.12 (2.609%)
Open: 4.90
High: 4.90
Low: 4.78
Prev. Close: 4.80
FP. Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FSA endorsement of the Constitutive Act amendments

17 Feb 2021 15:51

RNS Number : 4781P
Fondul Proprietatea S.A.
17 February 2021
 

To: Bucharest Stock Exchange

Financial Supervisory Authority

London Stock Exchange

 

Current report according Article 99 letter s) of the Code of the Bucharest Stock Exchange, Title II, Issuers and Financial Instruments

 

Important events to be reported:

The Financial Supervisory Authority Endorsement of the amendments to the Constitutive Act of Fondul Proprietatea SA

 

Franklin Templeton International Services S.À R.L., in its capacity as Alternative Investment Fund Manager and sole director of Fondul Proprietatea SA (the "Fund"), would like to inform shareholders that the Financial Supervisory Authority (the "FSA") issued the Endorsement no. 38 / 8 February 2021 (the "FSA Endorsement no. 38 / 8 February 2021"), whereby it endorsed a part of the amendments to the Fund's Constitutive Act, as approved by the Fund's Extraordinary General Shareholders' Meeting Resolution no. 4 of 13 November 2020 ("EGSM Resolution no. 4 / 13 November 2020"), namely the amendments of Article 12 para. (2) letter f), and of Article 12 para. (2) by introducing a new letter f^1).

 

The amendments of Article 28 para. (2), (3) and (5), and of Article 31 para. (1) letter d) were approved by shareholders through EGSM Resolution no. 4 / 13 November 2020 as already endorsed by the FSA through Endorsement no. 164 / 22 July 2020; thus they were not endorsed once again through FSA Endorsement no. 38 / 8 February 2021.

 

Also, through the FSA Endorsement no. 38 / 8 February 2021, the amendment of Article 33 approved through EGSM Resolution no. 4 / 13 November 2020 was endorsed with amendments by the FSA and it will be subject to a further Extraordinary General Shareholders' Meeting of the Fund.

 

Please find the English translation of the FSA Endorsement enclosed in the Annex to this report. Also, please note that the Fund's Constitutive Act in force can be accessed on the Fund's webpage, at: https://www.fondulproprietatea.ro/files/live/sites/fondul/files/en/corporate-governance/Constitutive%20Act%2015%20Feb%202021.pdf .

 

Franklin Templeton International Services S.À R.L. in its capacity of alternative investment fund manager and sole director of FONDUL PROPRIETATEA S.A.

 

Johan MEYER

Permanent Representative

 

http://www.rns-pdf.londonstockexchange.com/rns/4781P_1-2021-2-17.pdf

 

Report date:

17 February 2021

 

Name of the issuing entity:

Fondul Proprietatea S.A.

 

Registered office:

78-80 Buzesti Street

7th floor, district 1,

Bucharest, 011017

Phone/fax number:

Tel.: + 40 21 200 9600

Fax: + 40 21 200 9631

Email:

office@fondulproprietatea.ro

Internet:

www.fondulproprietatea.ro

Sole Registration Code with the Trade Register Office:

18253260

Order number in the Trade Register:

J40/21901/2005

Subscribed share capital:

RON 3,749,282,292.08

Paid-up share capital:

RON 3,560,099,870.08

Number of shares in issue:

7,210,158,254

Number of paid shares:

6,846,345,904

Regulated market on which the issued securities are traded:

Shares on Bucharest Stock ExchangeGDRs on London Stock Exchange

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAEASAXFDNFEFA
Date   Source Headline
21st Apr 20233:51 pmRNSThe resolutions of the OGSM and EGSM 21 Apr 2023
20th Apr 20237:04 amRNSEnel sale
18th Apr 20238:18 amRNSNotification buybacks 10 - 14 April 2023
13th Apr 20234:19 pmRNS31 March 2023 NAV report
13th Apr 20234:12 pmRNSMarch 2023 Factsheet
12th Apr 20234:08 pmRNSDisclosure of holdings over 5% of voting rights
12th Apr 20234:01 pmRNSDisclosure of holdings over 5% of voting rights
11th Apr 20237:00 amRNSShareholding structure as of 31 March 2023
11th Apr 20237:00 amRNSNotification buybacks 3 - 7 April 2023
5th Apr 20235:03 pmRNSDisclosure of holdings under 5% of voting rights
5th Apr 202312:28 pmRNSClosed trading period:12 April–12 May 2023
3rd Apr 20231:02 pmRNSNotification buybacks 27 - 31 March 2023
31st Mar 20232:07 pmRNSShareholding structure as of 23 March 2023
27th Mar 202310:23 amRNSNotification buybacks 20 - 24 March 2023
24th Mar 20232:20 pmRNSStrategy/Company/Ops Update
20th Mar 20233:40 pmRNSTransaction in Own Shares
16th Mar 20234:13 pmRNSSettlement and payment of tender offer transaction
15th Mar 20237:02 amRNS28 February 2023 NAV report
15th Mar 20237:00 amRNSFebruary 2023 Factsheet
14th Mar 20234:12 pmRNSTender Offer: GDRs exchange rate
14th Mar 20237:54 amRNSEnel S.p.A. notification on the tag along right
13th Mar 20235:03 pmRNSCompletion of the public tender offer
8th Mar 20233:57 pmRNS28 February 2023 Shareholder structure
8th Mar 20239:11 amRNSConvening notice republication 21 April 23 GSM
3rd Mar 20233:16 pmRNSErrata 21 April AGM Convening notice
28th Feb 20237:00 amRNSNotice of AGSM for 21 April 2023
28th Feb 20237:00 amRNSIndependent Auditor Report on 2022 Fin Statements
28th Feb 20237:00 amRNSAnnual Sole Director's Report for 2022
15th Feb 20237:00 amRNS31 January 2023 NAV report
15th Feb 20237:00 amRNSJanuary 2023 Factsheet
8th Feb 20232:30 pmRNS31 January 2023 Shareholding structure
6th Feb 202312:16 pmRNSPublication of the tender offer documentation
2nd Feb 20231:37 pmRNSApproval of the public tender offer
20th Jan 202312:35 pmRNSInformation on the closed trading period
17th Jan 20234:00 pmRNSPublic tender offer process
13th Jan 20234:27 pmRNSNet Asset Value(s)
13th Jan 20234:15 pmRNSDecember 2022 Factsheet
10th Jan 20233:43 pmRNSShareholding structure as of 31 December 2022
9th Jan 202312:29 pmRNSNotification buybacks 2 - 6 January 2023
3rd Jan 20233:40 pmRNSNotification buybacks 27 - 30 December 2022
29th Dec 20228:00 amRNSUpdate on the Fund's buyback programmes
28th Dec 20227:00 amRNSNotification buybacks 19 - 23 December 2022
28th Dec 20227:00 amRNSNotification buybacks 19 - 23 December 2022
16th Dec 20224:47 pmRNSOMV Petrom ABB offering settlement
15th Dec 20227:46 amRNS30 November 2022 NAV report
15th Dec 20227:43 amRNSNovember 2022 Factsheet
14th Dec 20227:00 amRNSCompletion of the ABB of OMV Petrom S.A.
13th Dec 20224:16 pmRNSLaunch of an ABB in OMV Petrom S.A.
13th Dec 20224:09 pmRNSUpdate regarding significant NAV changes
12th Dec 202212:27 pmRNSNotification buybacks 5 - 9 December 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.